Welcome to our dedicated page for Definitive Healthcare news (Ticker: DH), a resource for investors and traders seeking the latest updates and insights on Definitive Healthcare stock.
Definitive Healthcare Corp. (NASDAQ: DH) is a leading provider of healthcare commercial intelligence, specializing in delivering comprehensive data and analytics on healthcare providers and their activities. The company’s suite of solutions offers clients access to the most accurate and detailed information available, covering over 8,100 hospitals and Integrated Delivery Networks (IDNs), 7,300 ambulatory surgery centers, 11,000 imaging centers, 38,000 long-term care facilities, 1,200 Accountable Care Organizations (ACOs) and Health Information Exchanges (HIEs), 197,000 physician groups, 1.3 million physicians, and 750 Canadian hospitals.
Definitive Healthcare's robust data set helps organizations in the healthcare sector optimize everything from product development to go-to-market planning, and sales and marketing execution. Backed by Spectrum Equity, the company is committed to transforming data, analytics, and expertise into actionable healthcare commercial intelligence.
The company continually invests in enhancing its product offerings and expanding its data coverage. Recent achievements include a 14% year-over-year revenue growth in the third quarter, reaching $65.3 million. Additionally, Definitive Healthcare has forged strategic partnerships, such as the recent collaboration with VML Health to streamline engagement between pharmaceutical companies and Key Opinion Leaders (KOLs), leveraging the Monocl ExpertInsight platform.
Definitive Healthcare’s competitive edge lies in its ability to provide unparalleled insights into the healthcare provider market, which equips its clients with the necessary tools to identify and capitalize on new opportunities. The company’s platform supports clients in uncovering the right markets, opportunities, and individuals, thereby shaping the future of healthcare. With the majority of its revenue derived from the United States, Definitive Healthcare continues to be a pivotal player in the healthcare data analytics industry.
For more information, visit www.definitivehc.com.
Definitive Healthcare (Nasdaq: DH) has been awarded the 2024 Databricks Healthcare and Life Sciences Partner of the Year. This accolade highlights their successful collaboration with Databricks in offering innovative data and AI solutions to the healthcare and life sciences sector.
Leveraging the Databricks Marketplace, Definitive Healthcare provides access to extensive datasets, including prescription claims, behavioral health data, and affiliations intelligence. This aids organizations in understanding patient journeys, prioritizing opportunities, and engaging key medical experts for better healthcare outcomes.
Casey Eastlack, AVP at Definitive Healthcare, expressed pride in the recognition, emphasizing the shared mission to deliver deeper and faster healthcare insights for improved decision-making and innovation. Michael Sanky of Databricks praised the partnership's impact on advancing outcomes for customers in the sector.
Definitive Healthcare (Nasdaq: DH) published its 2023 Sustainability Report, showcasing its achievements in environmental, social, and governance (ESG) practices. Highlights include the retention of an ESG consultant to measure greenhouse gas emissions, and the closure of its least energy-efficient office. On the social front, the company improved diversity at the executive level, contributed 1,940 volunteer hours, and raised over $300,000 in charitable donations. In governance, Definitive Healthcare completed a SOC2 assessment and enhanced its cybersecurity and data privacy framework.
Definitive Healthcare, a leader in healthcare commercial intelligence, announced that Founder, Interim CEO, and Executive Chairman, Jason Krantz, will present at the Stifel 2024 Cross Sector Insight Conference. The presentation is scheduled for June 4, 2024, at 9:10 a.m. ET. A live webcast will be available on the Definitive Healthcare investor relations website, with a replay accessible for a time. The announcement highlights the company's active role in industry events and its ongoing efforts to engage with investors and stakeholders.
Definitive Healthcare (Nasdaq: DH) announced the appointment of Kevin Coop as CEO, effective June 24, 2024. Coop replaces Jason Krantz, who served as Interim CEO and will remain as Executive Chairman. Coop brings over 30 years of experience in operations, product, and revenue growth, including leadership roles at DailyPay, Dun & Bradstreet, Black Knight, and Verisk Analytics. The company aims to leverage Coop's expertise to capitalize on the $10 billion healthcare commercial intelligence market, enhancing growth, innovation, and operational efficiency.
On May 14, 2024, Definitive Healthcare announced that its Founder, Interim CEO, and Executive Chairman, Jason Krantz, will present at the 52nd Annual J.P. Morgan Global Technology, Media and Communications Conference. The presentation is scheduled for May 21, 2024, at 10:10 a.m. Eastern Time. A live webcast of the event will be available on the company's investor relations website, with a replay accessible for a period.
Definitive Healthcare reported a 7% increase in revenue to $63.5 million for the first quarter of fiscal year 2024. The company's adjusted EBITDA and net income also showed positive growth compared to the same period last year. Definitive Healthcare expanded its enterprise customer base and made significant customer wins. The Board of Directors approved a stock repurchase program of up to $20.0 million. The company issued financial guidance for the second quarter and full year 2024.
FAQ
What is the current stock price of Definitive Healthcare (DH)?
What is the market cap of Definitive Healthcare (DH)?
What services does Definitive Healthcare Corp. provide?
How does Definitive Healthcare’s data benefit its clients?
What is the geographic focus of Definitive Healthcare’s revenue?
Who backs Definitive Healthcare Corp.?
What recent financial achievement has Definitive Healthcare reported?
What recent partnerships has Definitive Healthcare formed?
What types of healthcare providers are included in Definitive Healthcare’s data?
How does Definitive Healthcare stay competitive in the market?
What is the Monocl ExpertInsight platform used for?
Where can I find more information about Definitive Healthcare?
